Moderna, Inc. (MRNA) Financials

$32.60

south_east
-$1.01 (-3.01%)
Day's range
$32.46
Day's range
$33.77

MRNA Income statement / Annual

Last year (2023), Moderna, Inc.'s total revenue was $6.85 B, a decrease of 64.45% from the previous year. In 2023, Moderna, Inc.'s net income was -$4.71 B. See Moderna, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $6.85 B $19.26 B $17.74 B $274.49 M $48.04 M $122.51 M $176.97 M $101.54 M
Cost of Revenue $4.69 B $5.42 B $2.62 B $7.93 M $31.02 M $454.08 M $20.54 M $15.11 M
Gross Profit $2.16 B $13.85 B $15.12 B $266.56 M $17.02 M -$331.57 M $156.44 M $86.42 M
Gross Profit Ratio 0.31 0.72 0.85 0.97 0.35 -2.71 0.88 0.85
Research and Development Expenses $4.85 B $3.30 B $1.99 B $1.37 B $496.31 M $454.08 M $410.46 M $274.72 M
General & Administrative Expenses $1.35 B $1.01 B $0.00 $0.00 $109.62 M $94.25 M $64.72 M $57.45 M
Selling & Marketing Expenses $204.00 M $121.00 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $1.55 B $1.13 B $567.00 M $188.27 M $109.62 M $94.25 M $64.72 M $57.45 M
Other Expenses -$94.00 M -$45.00 M -$735.00 M -$528.91 M $0.00 -$12.56 M -$28.85 M -$2.71 M
Operating Expenses $6.30 B $4.43 B $1.82 B $1.03 B $593.76 M $535.78 M $446.33 M $325.31 M
Cost And Expenses $11.09 B $9.84 B $4.44 B $1.04 B $593.76 M $535.78 M $446.33 M $325.31 M
Interest Income $421.00 M $200.00 M $18.00 M $24.72 M $38.53 M $27.02 M $15.24 M $11.31 M
Interest Expense $38.00 M $29.00 M $18.00 M $9.89 M $6.61 M $3.10 M $132,000.00 $0.00
Depreciation & Amortization $621.00 M $348.00 M $232.00 M $31.25 M $31.02 M $24.86 M $20.54 M $15.11 M
EBITDA -$3.28 B $9.77 B $13.53 B -$732.00 M -$515.00 M -$388.40 M -$235.33 M -$208.66 M
EBITDA Ratio -0.48 0.51 0.75 -2.78 -11.36 -3.37 -1.41 -2.06
Operating Income Ratio -0.62 0.49 0.75 -2.78 -11.36 -3.37 -1.52 -2.2
Total Other Income/Expenses Net $297.00 M $155.00 M -$11.00 M $18.63 M $31.00 M $28.86 M $13.36 M $8.60 M
Income Before Tax -$3.94 B $9.58 B $13.29 B -$744.51 M -$514.72 M -$384.41 M -$256.00 M -$215.17 M
Income Before Tax Ratio -0.58 0.5 0.75 -2.71 -10.72 -3.14 -1.45 -2.12
Income Tax Expense $772.00 M $1.21 B $1.08 B $2.55 M -$695,000.00 $326,000.00 -$80,000.00 $1.04 M
Net Income -$4.71 B $8.36 B $12.20 B -$747.06 M -$514.02 M -$384.73 M -$255.92 M -$216.21 M
Net Income Ratio -0.69 0.43 0.69 -2.72 -10.7 -3.14 -1.45 -2.13
EPS -12.34 21.22 30.28 -1.96 -1.55 -4.74 -0.68 -0.58
EPS Diluted -12.34 20.1 28.31 -1.96 -1.55 -4.74 -0.68 -0.58
Weighted Average Shares Out $382.00 M $394.00 M $403.00 M $381.33 M $330.80 M $81.11 M $376.00 M $376.00 M
Weighted Average Shares Out Diluted $382.00 M $416.00 M $431.00 M $381.33 M $330.80 M $81.11 M $376.00 M $376.00 M
Link